                         SEQUENCE LISTING

<110>  Imnate SARL
 
<120>  Fine-Tuning of the immune system

<130>  PAT84208EP00

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD1 NS Dengue


<220>
<221>  MISC_FEATURE
<222>  (3)..(9)
<223>  CD1 epitope

<400>  1

Ala Gly His Gly Gln Val Asp Asn Phe Ser Leu 
1               5                   10      


<210>  2
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Coxsackie B4 CD1 epitope


<220>
<221>  MISC_FEATURE
<222>  (3)..(9)
<223>  CD1 core epitope

<400>  2

Glu Lys Phe Arg Asp Ile Arg Gly Phe Leu Ala 
1               5                   10      


<210>  3
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  SARS COVID Spike CD1 epitope


<220>
<221>  MISC_FEATURE
<222>  (4)..(10)
<223>  CD1 core epitope

<400>  3

Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys 
1               5                   10              


<210>  4
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Influenza hemagglutinin CD1 epitope


<220>
<221>  MISC_FEATURE
<222>  (3)..(9)
<223>  CD1 core epitope

<400>  4

Gly Leu Phe Gly Ala Ile Ala Gly Phe Ile Glu 
1               5                   10      


<210>  5
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HSV Vp16 CD1 epitope


<220>
<221>  MISC_FEATURE
<222>  (3)..(9)
<223>  Core CD1 epitope

<400>  5

Val Leu Phe Leu His Leu Tyr Leu Phe Leu Thr 
1               5                   10      


